REG - Elixirr Intnl PLC - Issue of Equity - TRC Contingent Consideration

Elixirr InternationalAnnouncement

Wed 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260520:nRST9861Ea&default-theme=true

RNS Number : 9861E  Elixirr International PLC  20 May 2026

ELIXIRR INTERNATIONAL PLC

("Elixirr", the "Company" or the "Group")

Issue of Equity - TRC Contingent Consideration

Elixirr International plc (ELIX.L), an established, global award-winning
challenger consultancy, announces that, pursuant to the terms of the
acquisition of TRC Advisory, LLC ("Acquisition") in September 2025, the
Company has issued 822,194 new ordinary shares of £0.00005 each in the
capital of the Company ("New Ordinary Shares").

The issuance of New Ordinary Shares is to satisfy the equity element of
contingent consideration due in relation to the FY 25 performance of TRC
Advisory, LLC. The New Ordinary Shares are being issued at £7.20 per share
and a total value of £5.9 million (US$8.0 million), representing the maximum
value of equity contingent consideration available for FY 25 performance under
the terms of the Acquisition.

The New Ordinary Shares are subject to one-year lock-in arrangements plus
limitations on the number of shares which may be sold in each of the following
three years under nominee agreements.

Admission and Total Voting Rights

Application will be made to the London Stock Exchange for the 822,194 New
Ordinary Shares to be admitted to listing in the equity shares (commercial
companies) category of the Official List of the Financial Conduct Authority
(the "FCA") and to trading on the London Stock Exchange's Main Market for
listed securities ("Admission"). It is expected that Admission will become
effective at 8.00 a.m. on 26 May 2026.

The New Ordinary Shares will rank pari passu in all respects with the existing
issued ordinary shares of the Company.

After Admission, the total number of ordinary shares in issue will be
50,853,348, and the total number of voting rights will be 50,853,348.
Following Admission, this figure may be used by Company shareholders as the
denominator for the calculations by which they will determine if they are
required to notify their interest, or a change to their interest, in the share
capital of the Company under the FCA's Disclosure Guidance and Transparency
Rules.

 

Enquiries:

For enquiries, please refer to the Company's Investor Contacts page:

https://www.elixirr.com/investors/investor-contacts
(https://www.elixirr.com/investors/investor-contacts)

Elixirr International
plc                                                                 +44
(0)20 7220 5410

Stephen Newton, Chief Executive Officer

Graham Busby, Deputy Chief Executive Officer

Nicholas Willott, Chief Financial Officer and Company Secretary

investor-relations@elixirr.com

Cavendish Capital Markets Ltd
(Broker)                                 +44
(0)20 7220 0500

Stephen Keys, Callum Davidson, Isaac Hooper (Corporate Finance),

Sunila de Silva (ECM)

 

About Elixirr International plc

Elixirr is an award-winning global consulting firm working with clients across
a diverse range of industries, markets and geographies. Founded in 2009, the
firm set out to be the 'challenger consultancy' and do things differently than
the large corporate consultancies dominating the industry: working openly and
collaboratively with clients from start to finish, delivering outcomes based
on innovative thinking, not methodology, and treating each client's business
like their own. Elixirr was quoted on the AIM market of the London Stock
Exchange in 2020 and listed on the Main Market of the London Stock Exchange in
July 2025. In addition to strong organic growth, Elixirr has acquired nine
boutique firms - Den Creative, Coast Digital, The Retearn Group, iOLAP,
Responsum, Insigniam, Hypothesis, TRC Advisory, Kvadrant Consulting - to grow
the Group's capabilities, diversify the business, expand into new geographies
and access new clients.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEFLFFTESIALIR



            Copyright 2019 Regulatory News Service, all rights reserved